Quick Facts
  • Primary Location:
    Virginia Cancer Specialists
  • Expertise:
    Research
    Immunotherapy
  • Speciality:
    Medical Oncology
  • Gender:
    Male
  • Language:
    English
  • Med School:
    NYU School of Medicine

Dr. Alex Spira is the director of the Research Institute and Phase I Trial Program at Virginia Cancer Specialists, helping pioneer advances in cancer treatment.

He specializes in lung malignancies that include pleural mesothelioma, an aggressive cancer caused by exposure to asbestos.

Throughout his career, he has been recognized as an innovative researcher and an excellent clinician. He received the Castle Connolly America’s Top Doctor Award in 2014 and has been recognized several times as a top doctor by Northern Virginia Magazine and Washington Magazine.

His work with the multidisciplinary team at Virginia Cancer Specialists has allowed many cancer patients to thrive, despite an original diagnosis that suggested otherwise.

“We have a lot of patients who were supposed to be doing poorly — originally given a fatal diagnosis — but now are coming into our office with pictures of their grandkids, and that’s a great thing to see,” he said. “It’s nice to offer them hope, where otherwise there was no hope, offer them opportunity, when they didn’t have opportunity before.”

Contact Alex Spira

Leader in Immunotherapy Treatment

In addition to the most up-to-date standard treatment, Spira often offers patients novel therapies through clinical trials at VCS.

Many of those trials involve immunotherapy drugs, which many consider the future of cancer treatment.

“Our passion in caring for these patients often comes from the fact that these cancers are incredibly aggressive. The patients are sick,” he said. “We can offer them hope and treatment they can’t find anywhere else.”

A Passion for Research

As a research leader, Spira has stressed personalized treatment and targeted therapies. He is the co-chair of the U.S. Oncology Thoracic Committee and chair of the U.S. Oncology Research Executive Committee.

He also serves as an assistant professor of oncology at the Johns Hopkins School of Medicine.

Spira earned his degree from the New York University School of Medicine. He completed an internship and residency at the University of Pennsylvania, where he trained at the Abramson Cancer Center.

He also did a medical oncology fellowship at Johns Hopkins. He received his Ph.D. from the NYU College of Arts and Sciences.

He is affiliated today with Inova Fairfax Hospital and Inova Fair Oaks Hospital.


Lab technician using a microscope in a lab
COVID-19 and Mesothelioma Presentation
United States one-hundred-dollar bills
Access More than $32 Billion in Trust Funds
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

  •  
  •  
  •  
Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?